---
schema_version: "secwatch.filing_event.v1"
accession: "0001479681-25-000072"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-09-04T23:59:59+00:00"
generated_at: "2026-05-17T08:16:47.436469+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Nutex Health appoints Michael L. Reed as Lead Independent Director

## Summary
- Michael L. Reed appointed Lead Independent Director effective Sept 2, 2025.
- Reed has served on Nutex Health board since April 2022; member of Audit, Compensation, and Nominating/Governance committees.
- Role includes presiding over independent director sessions and serving as liaison between board and management.
- Reed will receive additional compensation per company's director compensation program as disclosed in June 2025 proxy.

## SEC filing metadata
- accession: 0001479681-25-000072
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-09-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000072/0001479681-25-000072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000072/nutx-20250904.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001479681-25-000072
- JSON: https://secwatch.observer/filing/0001479681-25-000072.json
- Plain text: https://secwatch.observer/filing/0001479681-25-000072.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.